Preclinical assessment of JNJ-26854165 (Serdemetan [1] Serdemetan is the proposed International Nonproprietary Name (pINN) for the generic name of JNJ-26854165. 1 ), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts

Autor:	Chargari, Cyrus1,2, Leteur, Celine1, Angevin, Eric3, Bashir, Tarig4, Schoentjes, Bruno4, Arts, Janine4, Janicot, Michel4, Bourhis, Jean1, Deutsch, Eric1 eric.deutsch@igr.fr
Zdroj:	Cancer Letters. Dec2011, Vol. 312 Issue 2, p209-218. 10p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect